NCT03765866

Brief Summary

This is a randomized controlled trial to compare viscoelastic (VE) guided resuscitation to fixed-ratio resuscitation in trauma patients with hemorrhagic shock on the utilization of blood products, effects on coagulation and inflammatory mediators, and how these strategies affect post resuscitation adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2016

Completed
2.5 years until next milestone

First Posted

Study publicly available on registry

December 5, 2018

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2018

Completed
Last Updated

May 29, 2020

Status Verified

May 1, 2020

Enrollment Period

2.6 years

First QC Date

May 23, 2016

Last Update Submit

May 27, 2020

Conditions

Keywords

rotational thromboelastometryviscoelastic testcoagulopathytraumahemorrhage

Outcome Measures

Primary Outcomes (1)

  • Change in number of blood products utilized at 24 hours

    Number of blood products utilized during that time frame will be recorded to determine if change in resuscitation strategies result in measurable differences

    24 hours from time of randomization

Secondary Outcomes (3)

  • Change in coagulation profile

    0 hours and 30 days

  • Change in inflammatory mediators

    0 hours and 30 days

  • Changes in Resuscitation strategy-related adverse events

    30 days after admission

Study Arms (2)

Massive Transfusion Protocol Guided

NO INTERVENTION

Clinicians will only transfuse patients according to standard massive transfusion protocol (MTP)

Thromboelastometry guided transfusion

EXPERIMENTAL

Clinicians will transfuse patients according to ROTEM results.

Procedure: Thromboelastometry guided transfusion

Interventions

Comparing resuscitation strategies with standard MTP v.s. ROTEM guided MTP

Thromboelastometry guided transfusion

Eligibility Criteria

Age14 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Trauma patient
  • MTP Activation
  • Only patients ≥ 14 years old
  • Alive at 31 mins after arrival in ED

You may not qualify if:

  • Transfer from OSH
  • Received CPR for more than 5 mins
  • Burned
  • Pregnant or Prisoner
  • Known DNR
  • Jehovah's witness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Memorial Hospital

Dallas, Texas, 75206, United States

Location

Related Publications (1)

  • Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schochl H. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med. 2013 Oct 8;21:74. doi: 10.1186/1757-7241-21-74.

    PMID: 24103457BACKGROUND

MeSH Terms

Conditions

Wounds and InjuriesHemostatic DisordersHemorrhage

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael W. Cripps, M.D.

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2016

First Posted

December 5, 2018

Study Start

May 1, 2016

Primary Completion

December 17, 2018

Study Completion

December 17, 2018

Last Updated

May 29, 2020

Record last verified: 2020-05

Locations